Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories abbott India — Operating Expenses (INR Crores)
Abbott India Limited Filings (NSE: ABBOTINDIA / Screener.in)
Latest, FY2025
4,714
Period ended Dec 31, 2025
Change on a year earlier
+7.2%
4,396 in FY2024
History
11 years
Since FY2015
Sources
1
Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Abbott Laboratories Abbott India — Operating Expenses (INR Crores), annual FY2015–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ind-expenses
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.